Other
Payments for Repurchase of Common Stock
Royalty Pharma Payments for Repurchase of Common Stock decreased by 37.8% to $50.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 92.9%, from $708.78M to $50.10M. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalLower is better
VolatilityModerate
First reportedQ1 2018
Last reportedQ1 2026May 6, 2026
How to read this metric
Higher spending indicates a commitment to returning capital to shareholders or offsetting dilution from stock-based compensation.
Detailed definition
The cash outflow associated with the company's repurchase of its own common shares from the open market. This is a prima...
Peer comparison
Standard capital return metric for mature public companies.
Metric ID:
other_payments_for_repurchase_of_common_stockHistorical Data
16 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q3 '22 | Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $140.12M | $30.20M | $0.00 | $80.00M | $97.05M | $52.61M | $708.78M | $291.57M | $146.49M | $80.54M | $50.10M |
| QoQ Change | — | — | — | — | — | — | -78.4% | -100.0% | — | +21.3% | -45.8% | >999% | -58.9% | -49.8% | -45.0% | -37.8% |
| YoY Change | — | — | — | — | — | — | — | — | — | -30.7% | +74.2% | — | +264.5% | +51.0% | +53.1% | -92.9% |
Range$0.00 – $708.78M
Avg YoY Growth+53.2%
Median YoY Growth+52.0%
Current Streak4 quarters decline
Payments for Repurchase of Common Stock at Other Companies
Frequently Asked Questions
- What is Royalty Pharma's payments for repurchase of common stock?
- Royalty Pharma (RPRX) reported payments for repurchase of common stock of $50.10M in Q1 2026.
- How has Royalty Pharma's payments for repurchase of common stock changed year-over-year?
- Royalty Pharma's payments for repurchase of common stock decreased by 92.9% year-over-year, from $708.78M to $50.10M.
- What does payments for repurchase of common stock mean?
- Cash spent by the company to buy back its own common stock.